Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vs low-dose remifentanil during gastrectomy
jRCT1091220090Recruiting
- Sponsor
- Kanagawa University of Human Services
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remifentanil in None (2 arms), sponsored by Kanagawa University of Human Services. Primary endpoints: Homeostasis model assessment as an index of insulin resistance (HOMA-IR) and 3-methylhistidine/creatinine (3-MH/Cr). Started Jun 2012; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on jRCT1091220090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220090.